Are there clinical phenotypes of homozygous sickle cell disease?

被引:50
|
作者
Alexander, N
Higgs, D
Dover, G
Serjeant, GR
机构
[1] London Sch Hyg & Trop Med, Infect Dis Epidemiol Unit, London WC1, England
[2] Weatherall Inst Mol Med, MRC, Mol Haematol Unit, Oxford, England
[3] Johns Hopkins Univ Hosp, Dept Pediat, Baltimore, MD 21287 USA
[4] Univ W Indies, MRC Labs Jamaica, Kingston 7, Jamaica
关键词
sickle cell; leg ulcers; painful crisis; clinical phenotypes; polymorphisms;
D O I
10.1111/j.1365-2141.2004.05025.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The distribution of clinical features was examined in subjects with homozygous sickle cell (SS) disease in the Jamaican Cohort Study to determine whether there is evidence of distinct clustering of symptoms or clinical phenotypes. A twofold model yielded groups that could be interpreted as painful crisis or leg ulcer phenotypes and 78% of patients were classified with 95% confidence into one of these. The painful crisis phenotype also manifested higher frequencies of dactylitis, meningitis/septicaemia, acute chest syndrome and stroke. Attempts to define a three-group model were less convincing although 43% of patients could be allocated with 95% confidence. The three-group model essentially divided subjects with the leg ulcer phenotype into subgroups with higher and lower frequencies of painful crisis, dactylitis, meningitis/septicaemia and acute chest syndrome. In the three-group model, the painful crisis phenotype had lower total haemoglobin, fetal haemoglobin, mean cell volume and higher reticulocytes but there was no apparent influence of alpha thalassaemia or beta globin haplotype. Both environmental and genetic factors are likely to contribute to most manifestations of SS disease and the evidence for different clinical phenotypes suggests that a search for associated genetic polymorphisms may provide insights into the mechanisms of clinical variability in SS disease.
引用
收藏
页码:606 / 611
页数:6
相关论文
共 50 条
  • [1] CLINICAL PRESENTATION OF HOMOZYGOUS SICKLE-CELL DISEASE
    BAINBRIDGE, R
    HIGGS, DR
    MAUDE, GH
    SERJEANT, GR
    JOURNAL OF PEDIATRICS, 1985, 106 (06): : 881 - 885
  • [2] Homozygous sickle cell disease
    Ouzzif, Z.
    Errifi, A.
    El Annaz, H.
    Benkirane, M.
    El Kabbaj, S.
    ANNALES DE BIOLOGIE CLINIQUE, 2007, 65 (01) : 117 - 119
  • [3] Benign clinical course in homozygous sickle cell disease: A search for predictors
    Thomas, PW
    Higgs, DR
    Serjeant, GR
    JOURNAL OF CLINICAL EPIDEMIOLOGY, 1997, 50 (02) : 121 - 126
  • [4] DEFINING THE PHENOTYPES OF SICKLE CELL DISEASE
    Ballas, Samir K.
    HEMOGLOBIN, 2011, 35 (5-6) : 511 - 519
  • [5] HOMOZYGOUS SICKLE-CELL DISEASE IN JAMAICA
    ENNIS, JT
    SERJEANT, GR
    MIDDLEMISS, H
    BRITISH JOURNAL OF RADIOLOGY, 1973, 46 (551): : 943 - 950
  • [6] Genetic modifiers of homozygous sickle cell disease
    Hartmann, K
    Kulozik, AE
    KLINISCHE PADIATRIE, 2006, 218 (03): : 170 - 173
  • [7] Is there an energy deficiency in homozygous sickle cell disease?
    Singhal, A
    Davies, P
    Wierenga, KJJ
    Thomas, P
    Serjeant, G
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 1997, 66 (02): : 386 - 390
  • [8] Energy balance in homozygous sickle cell disease
    Buchowski, MS
    Sun, M
    Chen, KY
    Turner, EA
    FASEB JOURNAL, 1997, 11 (03): : 2562 - 2562
  • [9] Recurrent infections in homozygous sickle cell disease
    Magnus, SA
    Hambleton, IR
    Moosdeen, F
    Serjeant, GR
    ARCHIVES OF DISEASE IN CHILDHOOD, 1999, 80 (06) : 537 - 541
  • [10] Erythrocyte aggregation in homozygous sickle cell disease
    Vaya, Amparo
    Collado, Susana
    Alis, Rafael
    Dasi, Maria-Angeles
    CLINICAL HEMORHEOLOGY AND MICROCIRCULATION, 2014, 58 (03) : 475 - 477